IMPOWER-QoL: IMPact Of Discontinuing Premedication for WEekly Paclitaxel on bReast Cancer Patient's Quality Of Life

NCT07478315 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: withdrawal of the premedication

Sponsor

Charles LeMoyne Hospital